4//SEC Filing
VAN BEEK JEROEN B 4
Accession 0000899243-22-025233
CIK 0001754068other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 7:30 AM ET
Size
9.6 KB
Accession
0000899243-22-025233
Insider Transaction Report
Form 4
Allovir, Inc.ALVR
VAN BEEK JEROEN B
Chief Commercial Officer
Transactions
- Award
Common Stock
2022-07-01+14,000→ 403,011 total - Award
Stock Option (Right to Buy)
2022-07-01+26,000→ 26,000 totalExercise: $4.13Exp: 2032-07-01→ Common Stock (26,000 underlying) - Sale
Common Stock
2022-06-03$3.63/sh−515$1,871→ 389,011 total
Footnotes (4)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs"), and does not represent a discretionary trade by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.60 to $3.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]The shares reported in this transaction represent RSUs issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on July 1, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.
- [F4]25% of this option shall vest and become exercisable on July 1, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.
Documents
Issuer
Allovir, Inc.
CIK 0001754068
Entity typeother
Related Parties
1- filerCIK 0001743662
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 7:30 AM ET
- Size
- 9.6 KB